Viewing Study NCT04828161

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:06 PM
Ignite Modification Date: 2026-01-31 @ 11:26 PM
Study NCT ID: NCT04828161
Status: TERMINATED
Last Update Posted: 2023-01-18
First Post: 2021-03-24
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Dose Finding, Efficacy and Safety Study of Ensovibep (MP0420) in Ambulatory Adult Patients With Symptomatic COVID-19
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None COVID-19 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SARS-CoV-2 View
None ensovibep View
None COVID-19 treatment, symptom reduction, viral load reduction, View
None EMPATHY View
None designed ankyrin repeat protein (DARPin®) View
None angiotensin-converting enzyme 2 (ACE2) View